High cancer drug prices are influenced by the availability of generic cancer drugs in a timely manner. Several strategies have been used to delay the availability of affordable generic drugs into the United States and world markets. These include: reverse payment or pay-for-delay, patent settlements, authorize generics, product hopping, lobbying against cross-border drug importation, buying out the competition, and others. In this Forum, we detail these strategies and how they can be prevented.
- Submitted November 5, 2015.
- Accepted December 10, 2015.
- Copyright © 2016 American Society of Hematology